止血劑市場規模、佔有率及成長分析（按類型、劑型、應用、最終用戶和地區分類）－2026-2033年產業預測

全球止血劑市場規模預計在 2024 年達到 32 億美元，從 2025 年的 34.2 億美元成長到 2033 年的 58.3 億美元，在預測期（2026-2033 年）內複合年成長率為 6.9%。

全球止血劑市場的發展主要受外科手術和急診護理中對高效止血需求的不斷成長所驅動，這促使產品研發和臨床實踐發生顯著變革。該市場涵蓋多種先進的局部用藥、貼片、密封劑和流動性材料，可在縫合和電凝等傳統方法無效時取代這些產品。生物材料和應用技術的創新正在提升其臨床效用，並拓展其在各個外科領域的應用。輸血量的減少和復原時間的縮短顯著改善了患者的治療效果。人口老化、手術量的增加以及新興市場醫保報銷範圍的擴大，都為市場創造了新的商機。各公司正致力於開發更安全的配方和更具成本效益的生產方式，以提高止血劑在各種醫療環境中的應用率並最佳化治療效果。

全球止血劑市場促進因素

全球外科手術數量的不斷成長推動了止血產品的需求。隨著醫療專業人員在各個醫學領域積極尋求可靠的止血方法，這一趨勢促使醫院和手術中心將先進的止血劑納入標準手術流程，從而提高手術效率並改善患者預後。隨著臨床醫生對這些產品的了解日益加深，醫療機構也鼓勵其使用，更廣泛的應用促使製造商拓展分銷管道並投資培訓計畫。這種認知度提升和機構支持的良性循環，顯著促進了止血劑市場的持續成長。

限制全球止血劑市場的因素

全球止血劑市場面臨許多挑戰，主要原因是先進止血劑高成本且醫保報銷政策不統一。這種經濟負擔往往會阻礙醫療機構採用更昂貴的止血方案，即使這些方案具有明顯的臨床效益。受預算限制的採購委員會往往優先考慮價格較低廉的傳統產品，阻礙了創新止血產品的市場推廣。此外，難以獲得穩定的健保報銷增加了採購方和生產商的財務風險，最終抑制了投資，延緩了新技術在臨床實踐中的應用。這反過來又限制了這些產品在患者照護中的接受度和使用。

全球止血劑市場趨勢

全球止血劑市場的一個顯著趨勢是，由於微創手術的日益普及和患者預後改善的推動，先進的生物製藥和合成替代製劑的應用日益廣泛。與傳統止血劑相比，這些創新產品能夠快速有效地形成血栓並降低併發症風險，這主要是推動市場對這些產品的青睞。此外，手術量和創傷病例的增加以及人口老化也促進了市場需求。同時，止血產品的技術進步，例如改進的給藥系統和特殊配方，也不斷重塑市場競爭格局，吸引著主要市場參與者的大量投資和關注。

目錄

介紹

• 調查目標
• 市場定義和範圍

調查方法

• 調查過程
• 二手資料和一手資料方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭格局概述

市場動態與展望

• 總體經濟指標
• 促進因素和機遇
• 限制與挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場考察

• 關鍵成功因素
• 影響市場的因素
• 關鍵投資機會
• 生態系測繪
• 市場吸引力指數（2025）
• PESTEL 分析
• 價值鏈分析
• 定價分析
• 案例研究
• 監管環境
• 技術評估

全球止血鉗市場規模（按類型及複合年成長率分類）（2026-2033 年）

• 活性止血劑
  • 基於凝血酶的止血劑
  • 氧化再生纖維素止血劑
  • 複方止血劑
  • 明膠基止血劑
  • 膠原蛋白蛋白止血劑
  • 其他
• 被動止血劑
  • 植物來源止血劑
  • 動物源性止血劑
  • 其他

全球止血鉗市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 基質凝膠止血劑
• 止血墊/片
• 海綿止血劑
• 粉狀止血劑

全球止血鉗市場規模（依應用領域及複合年成長率分類）（2026-2033 年）

• 整形外科手術
• 一般外科
• 神經外科
• 心血管外科
• 重組手術
• 婦科手術
• 創傷管理
• 整形外科
• 牙科治療
• 其他

全球止血鉗市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 門診手術中心
• 專科診所
• 護理機構
• 其他

全球止血劑市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Baxter International
• B.Braun Melsungen AG
• Becton Dickinson and Company
• Integra Life Sciences Holding Corporation
• Johnson and Johnson
• Medtronic Plc
• Pfizer
• Stryker Corporation
• Teleflex Incorporated
• Artivion, Inc.
• Biom'up
• Advanced Medical Solutions Group PLC
• Samyang Corporation
• Haemonetics Corporation
• Ethicon Inc.（a subsidiary of Johnson & Johnson）
• CR Bard, Inc.
• CryoLife, Inc.
• Terumo Corporation
• AngioDynamics, Inc.
• Cohera Medical, Inc.

結論與建議

Global Hemostats Market size was valued at USD 3.2 Billion in 2024 and is poised to grow from USD 3.42 Billion in 2025 to USD 5.83 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global hemostats market is driven by the increasing demand for efficient bleeding control in surgical and emergency settings, leading to a significant evolution in product development and clinical practices. This market includes advanced types such as topical agents, patches, sealants, and flowable materials, which replace traditional methods when sutures or electrocautery fall short. Innovations in biomaterials and application techniques have enhanced clinical utility and broadened their use across various surgical disciplines, significantly improving patient outcomes by reducing transfusions and accelerating recovery times. The aging population, rising surgical volumes, and expanding reimbursement options in emerging markets present new commercial opportunities. Companies are focusing on the development of safer formulations and cost-effective manufacturing to facilitate broader adoption and optimize treatment efficiency in diverse healthcare environments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemostats market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemostats Market Segments Analysis

Global hemostats market is segmented by type, formulation, application, end user and region. Based on type, the market is segmented into Active Hemostats and Passive Hemostats. Based on formulation, the market is segmented into Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats and Powder Hemostats. Based on application, the market is segmented into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Trauma Management, Plastic Surgery, Dental Treatments and Other Applications. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Nursing Homes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hemostats Market

The demand for hemostatic products is being propelled by the rising number of surgical procedures performed globally, as healthcare professionals actively seek dependable methods to control bleeding in various medical specialties. This trend leads hospitals and surgical centers to adopt advanced hemostats as part of their standard operating procedures, enhancing procedural efficiency and improving patient outcomes. As clinicians become more acquainted with these products and institutions endorse their use, broader adoption occurs, prompting manufacturers to invest in expanding distribution channels and training programs. This cycle of increased familiarity and institutional backing significantly contributes to ongoing growth in the hemostats market.

Restraints in the Global Hemostats Market

The Global Hemostats market faces significant challenges due to high costs associated with advanced hemostatic agents and the variability in reimbursement policies. This financial strain discourages healthcare facilities from adopting these pricier options, even when they offer clear clinical benefits. Budget-conscious procurement committees tend to prioritize more affordable or conventional alternatives, hindering the integration of innovative hemostatic products in the market. Additionally, the difficulties in obtaining consistent reimbursement create increased financial risk for both buyers and manufacturers, which ultimately stifles investment and slows the introduction of new technologies into clinical settings, thereby limiting their acceptance and usage in patient care.

Market Trends of the Global Hemostats Market

A notable trend in the global hemostats market is the increasing adoption of advanced biologics and synthetic alternatives, driven by a rising emphasis on minimally invasive surgical procedures and improved patient outcomes. The shift towards these innovations is largely fueled by their effectiveness in rapid clot formation and reduced risk of complications compared to traditional hemostatic agents. Additionally, the growing prevalence of surgical procedures and trauma cases, alongside an aging population, is propelling demand. Furthermore, technological advancements in hemostatic products, such as enhanced delivery systems and tailored formulations, continue to shape the competitive landscape, attracting significant investment and interest from key players in the market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Hemostats Market Size by Type & CAGR (2026-2033)

• Market Overview
• Active Hemostats
  • Thrombin-based Hemostats
  • Oxidized Regenerated Cellulose-based Hemostats
  • Combination Hemostats
  • Gelatin-based Hemostats
  • Collagen-based Hemostats
  • Other Active Hemostats
• Passive Hemostats
  • Plant-based Hemostats
  • Animal-based Hemostats
  • Other Passive Hemostats

Global Hemostats Market Size by Formulation & CAGR (2026-2033)

• Market Overview
• Matrix & Gel Hemostats
• Sheet & Pad Hemostats
• Sponge Hemostats
• Powder Hemostats

Global Hemostats Market Size by Application & CAGR (2026-2033)

• Market Overview
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Trauma Management
• Plastic Surgery
• Dental Treatments
• Other Applications

Global Hemostats Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Nursing Homes
• Others

Global Hemostats Market Size & CAGR (2026-2033)

• North America (Type, Formulation, Application, End User)
  • US
  • Canada
• Europe (Type, Formulation, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Formulation, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Formulation, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Formulation, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Baxter International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B.Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra Life Sciences Holding Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson and Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artivion, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biom'up
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Medical Solutions Group PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samyang Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ethicon Inc. (a subsidiary of Johnson & Johnson)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.R. Bard, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohera Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations